Education
About Us
Working with TipRanks
Follow Us
Edesa Biotech Inc (EDSA)
NASDAQ:EDSA
Total Valuation
Edesa Biotech has a market cap or net worth of $8.29M. The enterprise value is -$5.37M.
Market Cap$8.29M
Enterprise Value-$5.37M
Share Statistics
Edesa Biotech has 8,348,161 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,348,161
Owned by Insiders16.75%
Owned by Institutions33.86%
Financial Efficiency
Edesa Biotech’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -63.54%.
Return on Equity (ROE)-0.58
Return on Assets (ROA)-0.53
Return on Invested Capital (ROIC)-63.54%
Return on Capital Employed (ROCE)-0.64
Revenue Per Employee0.00
Profits Per Employee-449.10K
Employee Count16
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Edesa Biotech is ―. Edesa Biotech’s PEG ratio is 0.06.
PE Ratio―
PS Ratio0.00
PB Ratio1.13
Price to Fair Value1.13
Price to FCF-1.91
Price to Operating Cash Flow-0.80
PEG Ratio0.06
Income Statement
In the last 12 months, Edesa Biotech had revenue of 0.00 and earned -7.19M in profits. Earnings per share was -1.27.
Revenue0.00
Gross Profit-119.27K
Operating Income-7.91M
Pretax Income-7.18M
Net Income-7.19M
EBITDA-7.07M
Earnings Per Share (EPS)-1.27
Cash Flow
In the last 12 months, operating cash flow was -7.94M and capital expenditures 7.00, giving a free cash flow of -7.89M billion.
Operating Cash Flow-7.94M
Free Cash Flow-7.89M
Free Cash Flow per Share-0.95
Dividends & Yields
Edesa Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change-64.29%
50-Day Moving Average1.36
200-Day Moving Average1.96
Relative Strength Index (RSI)18.71
Average Volume (3m)93.40K
Important Dates
Edesa Biotech upcoming earnings date is May 8, 2026, After Close (Not Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
Edesa Biotech as a current ratio of 10.67, with Debt / Equity ratio of 0.00%
Current Ratio10.67
Quick Ratio10.67
Debt to Market Cap0.00
Net Debt to EBITDA1.53
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Edesa Biotech has paid 800.00 in taxes.
Income Tax800.00
Effective Tax Rate>-0.01
Enterprise Valuation
Edesa Biotech EV to EBITDA ratio is -0.46, with an EV/FCF ratio of -0.44.
EV to Sales0.00
EV to EBITDA-0.46
EV to Free Cash Flow-0.44
EV to Operating Cash Flow-0.44
Balance Sheet
Edesa Biotech has $12.05M in cash and marketable securities with $0.00 in debt, giving a net cash position of $12.05M billion.
Cash & Marketable Securities$12.05M
Total Debt$0.00
Net Cash$12.05M
Net Cash Per Share$1.44
Tangible Book Value Per Share$1.85
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Edesa Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast30.29%